SARS-CoV-2

Evolution and Epidemiology of SARS-CoV-2 Virus. - Molecular Epidemiology of SARS-CoV-2 by Sequencing. - Advanced Genetic Methodologies in Tracking Evolution and Spread of SARS-CoV-2. - Antigen-Based Point of Care Testing (POCT) for Diagnosing SARS-CoV-2: Assessing Performance. - Diagnostic Method for COVID-19 Using Sugar Chain-Immobilized Nanoparticles and Saliva Specimens. - Detection and Quantification of SARS-CoV-2 by Real-Time RT-PCR Assay. - Immunofluorescent Antibody Techniques in the Diagnosis of SARS-CoV-2 Infection in Humans. - Propagation and Quantification of SARS-CoV-2. - Quantification of Infectious SARS CoV 2 by the 50% Tissue Culture Infectious Dose Endpoint Dilution Assay. - One-Step Reverse Transcription Droplet Digital PCR Protocols for SARS-CoV-2 Detection and Quantification. - Profiling SARS-CoV-2 Infection by High-Throughput Shotgun Proteomics. - Detection of SARS-CoV-2 by Mass Spectrometry. - Bioinformatics-Based Approaches to Study Virus Host InteractionsDuring SARS-CoV-2 Infection. - Human Nasal Epithelial Cells (hNECs) Generated by Air-Liquid Interface (ALI) Culture as a Model System for Studying the Pathogenesis of SARS-CoV-2. - Animal Models of COVID-19: Nonhuman Primates. - Animal Models of COVID-19: Transgenic Mouse Model. - Immunohistochemical Detection of SARS-CoV-2 Antigens, by Single and Multiple Immunohistochemistry. - Measuring Neutralizing Antibodies to SARS-CoV-2 Using Lentiviral Spike-Pseudoviruses. - Antiviral Strategies Against SARS-CoV-2: A Systems Biology Approach. - Neutralization Assay for SARS-CoV-2 Infection: Plaque Reduction Neutralization Test. - Pseudovirus-Based Assays for the Measurement of Antibody-Mediated Neutralization of SARS-CoV-2. - Cytopathic Effect (CPE)-Based Drug Screening Assay for SARS-CoV-2. - Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents like SARS-CoV-2. - Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility. - Methods of SARS-CoV-2 Inactivation.